This is the part that makes me think there will be
Post# of 148175
"Update Call CatalystsThe call after the bell today could be a major momentum driver if they pin down the release date of the efficacy data in the CD10 (mild to moderate) trial or reveal when the Data Safety Monitoring Committee will have a peek at the CD12 study (severe to critical). "